相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。EpiCO (epirubicin, cyclophosphamide and vincristine) as treatment for extrapulmonary high-grade neuroendocrine neoplasms
Stefan Munker et al.
ZEITSCHRIFT FUR GASTROENTEROLOGIE (2020)
Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer
Tsvetelina Veselinova Velikova et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
Uddalak Bharadwaj et al.
PHARMACOLOGICAL REVIEWS (2020)
Piperine inhibits colorectal cancer migration and invasion by regulating STAT3/Snail-mediated epithelial-mesenchymal transition
Lingyu Song et al.
BIOTECHNOLOGY LETTERS (2020)
Enhanced anti-tumor effects of the PD-1 blockade combined with a highly absorptive form of curcumin targeting STAT3
Taeko Hayakawa et al.
CANCER SCIENCE (2020)
Ailanthone: A novel potential drug for treating human cancer
Haixiang Ding et al.
ONCOLOGY LETTERS (2020)
A Phase Ib/II Study of the JAK1 Inhibitor, Itacitinib, plus nab-Paclitaxel and Gemcitabine in Advanced Solid Tumors
Gregory L. Beatty et al.
ONCOLOGIST (2019)
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression
Martina Daga et al.
PHYTOMEDICINE (2019)
被撤回的出版物: Ailanthone up-regulates miR-449a to restrain acute myeloid leukemia cells growth, migration and invasion (Retracted article. See vol. 126, 2022)
Yang Zhang et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2019)
Ailanthone Induces Cell Cycle Arrest and Apoptosis in Melanoma B16 and A375 Cells
Wenjing Liu et al.
BIOMOLECULES (2019)
Matrine enhances the efficacy of adriamycin chemotherapy in osteosarcoma cells by the STAT3 pathway
Houming Zhou et al.
ANTI-CANCER DRUGS (2019)
Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience
Sema Bueyukkapu Bay et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Rafael Caparica et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
被撤回的出版物: Ailanthone exerts an antitumor function on the development of human lung cancer by upregulating microRNA-195 (Retracted article. See vol. 122, pg. 489, 2021)
Shizhen Hou et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Highlighted STAT3 as a potential drug target for cancer therapy
Haeri Lee et al.
BMB REPORTS (2019)
The challenge of drug resistance in cancer treatment: a current overview
Michail Nikolaou et al.
CLINICAL & EXPERIMENTAL METASTASIS (2018)
Luteolin-Mediated Inhibition of Hepatic Stellate Cell Activation via Suppression of the STAT3 Pathway
Claire B. Cummins et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evaluation of health-related quality of life and symptoms in patients with advanced non-squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 057
Martin Reck et al.
EUROPEAN JOURNAL OF CANCER (2018)
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer
David Fogelman et al.
CANCER MEDICINE (2018)
Ailanthone induces G2/M cell cycle arrest and apoptosis of SGC-7901 human gastric cancer cells
Yuxin Chen et al.
MOLECULAR MEDICINE REPORTS (2017)
Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer
Cong Han et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2017)
Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer
Jun Zeng et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Ailanthone inhibits non-small cell lung cancer cell growth through repressing DNA replication via downregulating RPA1
Zhongya Ni et al.
BRITISH JOURNAL OF CANCER (2017)
Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer
Yundong He et al.
NATURE COMMUNICATIONS (2016)
Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition
Hong Liu et al.
CARCINOGENESIS (2015)
HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells
Dae-Hee Lee et al.
CELLULAR SIGNALLING (2015)
Overcome Cancer Cell Drug Resistance Using Natural Products
Pu Wang et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
David Hong et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer
Fanghua Qi et al.
BIOSCIENCE TRENDS (2015)
Ailanthone Inhibits Huh7 Cancer Cell Growth via Cell Cycle Arrest and Apoptosis In Vitro and In Vivo
Zhenjian Zhuo et al.
SCIENTIFIC REPORTS (2015)
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Do-Youn Oh et al.
CANCER RESEARCH AND TREATMENT (2015)
c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
Kyu Sang Lee et al.
PLOS ONE (2015)
A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
Eric Angevin et al.
CLINICAL CANCER RESEARCH (2014)
JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells
Reng-Yun Liu et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
Simaroubaceae family: botany, chemical composition and biological activities
Iasmine A. B. S. Alves et al.
REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY (2014)
Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development
Maximilian J. Waldner et al.
SEMINARS IN IMMUNOLOGY (2014)
Programmed Cell Death in Animal Development and Disease
Yaron Fuchs et al.
CELL (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Aspirin promotes apoptosis in a murine model of colorectal cancer by mechanisms involving downregulation of IL-6-STAT3 signaling pathway
Yun Tian et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2011)
Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
Man-Yi Wong et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Cyclin-Dependent Kinase 1-Mediated Bcl-xL/Bcl-2 Phosphorylation Acts as a Functional Link Coupling Mitotic Arrest and Apoptosis
David T. Terrano et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Overexpression of GRIM-19 in Cancer Cells Suppresses STAT3-Mediated Signal Transduction and Cancer Growth
Takashi Okamoto et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy
Min H. Kang et al.
CLINICAL CANCER RESEARCH (2009)
Stat3 Is Involved in Angiotensin II-Induced Expression of MMP2 in Gastric Cancer Cells
Wei Huang et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells
Hua Xiong et al.
NEOPLASIA (2008)
Cyclin D1 is transcriptionally regulated by and required for transformation by activated signal transducer and activator of transcription 3
K Leslie et al.
CANCER RESEARCH (2006)
The viral death effector Apoptin reveals tumor-specific processes
JL Rohn et al.
APOPTOSIS (2004)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
分享论文
